Seeing Is Believing

Currently out of the existing stock ratings of Florent Cespedes, 1 are a HOLD (12.5%), 3 are a SELL (37.5%), 4 are a BUY (50%).
Analyst Florent Cespedes, currently employed at SOCGEN, carries an average stock price target met ratio of 50% that have a potential upside of 18.41% achieved within 345 days.
Florent Cespedes’s has documented 16 price targets and ratings displayed on 4 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on LLY, Eli Lilly and Company at 16-Feb-2023.
Analyst best performing recommendations are on NVO (NOVO NORDISK A/S).
The best stock recommendation documented was for NVO (NOVO NORDISK A/S) at 11/3/2020. The price target of $30.79 was fulfilled within 1 day with a profit of $0.83 (2.77%) receiving and performance score of 27.7.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 17-Nov-2022
$1250
$198.01 (18.82%)
$1080
5 days ago
(25-Feb-2026)
13/14 (92.86%)
$207.85 (19.94%)
136
Buy Since 24-Jan-2022
$1313
$261.01 (24.81%)
$1290
25 days ago
(05-Feb-2026)
33/42 (78.57%)
$293.86 (28.83%)
201
Buy Since 15-Nov-2016
$1300
$248.01 (23.58%)
$1150
25 days ago
(05-Feb-2026)
33/35 (94.29%)
$280.86 (27.56%)
269
Buy Since 27-Feb-2020
$1205
$153.01 (14.54%)
$985
25 days ago
(05-Feb-2026)
17/18 (94.44%)
$185.86 (18.24%)
145
Buy Since 13-Mar-2023
$1280
$228.01 (21.67%)
$1200
25 days ago
(05-Feb-2026)
20/22 (90.91%)
$260.86 (25.60%)
136
What Year was the first public recommendation made by Florent Cespedes?